Pangolins’ genetic makeup linked to increased coronavirus susceptibility

Research reveals pangolins’ vulnerability to coronavirus due to innate immune gene pseudogenization, impacting their antiviral response.

Fractyl has the GUTS: Obesity and diabetes biotech charts $99M IPO

Fractyl Health is attempting to ride the waves created by last week’s successful biotech IPOs for cancer drugmakers CG Oncology and ArriVent Biopharma. The cardiometabolic

January 30, 2024

Aurora Q3 Cannabis Sales Slip 3% to C$53.3 Million

Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results Achieves Second Sequential Quarter of Positive Adjusted EBITDA1 Net Revenue Reaches $64 Million,

June 14, 2023

Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar – Biotech Investments

EQS-News: Formycon AG / Key word(s): Agreement/Market Launch Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar 07.08.2023 / 08:00 CET/CEST The

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.